Aucta Pharmaceuticals, Inc. (AUCTA, Latin: improved, enhanced) is a technology-based company focusing on the development and commercialization of Branded Specialty Products. We create enhanced products from proven molecules using the 505(b)(2) regulatory pathway, and we have a clear therapeutic focus in epilepsy, other CNS disorders, Ophthalmics and Inhalation therapy. We are committed to being patient-centric by continuously bringing improved forms of proven molecules into the marketplace.
Visit us at https://www.auctapharma.com/
Aucta Pharmaceuticals, Inc. is a technology-based company focusing on development and commercialization of Branded Specialty Products. Leveraging 505(b)(2) regulatory pathway, we create enhanced products from proven molecules, and we have a clear therapeutic focus in epilepsy, other CNS disorders, Ophthalmics and Inhalation therapy. We are committed to being patient-centric by continuously bringing improved forms of proven molecules into marketplace. Visit us at https://www.auctapharma.com/